Warner Chilcott Settles Securities Case For $16.5M
The settlement, announced Tuesday, is still subject to court approval and negotiation of definitive documentation.
If it becomes final, all charges would be dropped against the specialty pharmaceutical company, Chief Executive Officer Roger Boissonneault, Chief Financial Officer Paul Herendeen and the underwriters of the...
Already a subscriber? Click here to login